Citation Impact

Citing Papers

Multi-Institutional Randomized Phase II Trial of Gefitinib for Previously Treated Patients With Advanced Non–Small-Cell Lung Cancer
2003 Standout
Active replication of HIV-1 at the lymphoepithelial surface of the tonsil.
1997 StandoutNobel
Untangling the ErbB signalling network
2001 Standout
British Thoracic Society guideline for diagnostic flexible bronchoscopy in adults: accredited by NICE
2013 Standout
A Combination of Chemoimmunotherapies Can Efficiently Break Self-Tolerance and Induce Antitumor Immunity in a Tolerogenic Murine Tumor Model
2007 StandoutNobel
Prognostic relevance of epidermal growth factor receptor (EGF-R) and c-neu/erbB2 expression in glioblastomas (GBMs)
1993
Immunocytochemical markers in stage I lung cancer: relevance to prognosis.
1997
EGFR and cancer prognosis
2001 Standout
Lack of prognostic significance of epidermal growth factor receptor and the oncoprotein p185HER-2 in patients with systemically untreated non-small-cell lung cancer: an immunohistochemical study on cryosections
1996
ERBB receptors and cancer: the complexity of targeted inhibitors
2005 Standout
EGFR Antagonists in Cancer Treatment
2008 Standout
Epidermal growth factor receptor gene amplification and expression in head and neck cancer cell lines
1989
A comparison of epidermal growth factor receptor levels and other prognostic parameters in non-small cell lung cancer
1996
Malignant pleural mesothelioma and epidermal growth factor receptor (EGF-R). Relationship of EGF-R with histology and survival using fixed paraffin embedded tissue and the F4, monoclonal antibody
1990
Transient expression of IL-1β induces acute lung injury and chronic repair leading to pulmonary fibrosis
2001 Standout
Epidermal growth factor-related peptides and their receptors in human malignancies
1995 Standout
The 2004 World Health Organization classification of lung tumors
2005 Standout
Efficacy of Gefitinib, an Inhibitor of the Epidermal Growth Factor Receptor Tyrosine Kinase, in Symptomatic Patients With Non–Small Cell Lung Cancer
2003 Standout
Epidermal growth factor receptor mutations in lung cancer
2007 Standout
Autocrine growth stimulation by transforming growth factor-α in human non-small cell lung cancer
1992
A genetic model for colorectal tumorigenesis
1990 Standout
The human keratins: biology and pathology
2008 Standout
EMT Transition States during Tumor Progression and Metastasis
2018 Standout
Expression of epidermal growth factor receptor in normal colorectal mucosa, adenoma, and carcinoma
1990
Epidermal growth factor receptor in adenocarcinoma of the kidney
1989
Cetuximab Monotherapy and Cetuximab plus Irinotecan in Irinotecan-Refractory Metastatic Colorectal Cancer
2004 Standout
Tight junction-related structures in the absence of a lumen: Occludin, claudins and tight junction plaque proteins in densely packed cell formations of stratified epithelia and squamous cell carcinomas
2003
Co-expression of epidermal growth factor receptor and transforming growth factor-α is independent of ras mutations in lung adenocarcinoma
2000
Tumor suppressor genes
1991 Standout
Hippo Pathway in Organ Size Control, Tissue Homeostasis, and Cancer
2015 Standout
Prognostic impact of histologic demonstration of Chromogranin A and Neuron Specific Enolase in pulmonary adenocarcinoma
1991
A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma
1997 Standout
Erlotinib in Previously Treated Non–Small-Cell Lung Cancer
2005 Standout
Prediction of post‐translational glycosylation and phosphorylation of proteins from the amino acid sequence
2004 Standout
The effect of the JE (MCP‐1) gene, which encodes monocyte chemoattractant protein‐1, on the growth of hela cells and derived somatic‐cell hybrids in nude mice
1995 StandoutNobel
Interstitial lung disease guideline
2008
The new World Health Organization classification of lung tumours
2001
The p53 tumour suppressor gene
1991 StandoutNature
Growth control by epidermal growth factor and transforming growth factor-α in human lung squamous carcinoma cells
1992
Increased expression of mutant forms of p53 oncogene in primary lung cancer
1990
The epidermal growth factor receptor and its ligands as therapeutic targets in human tumors
1996
Correlation of epidermal growth factor receptor and c-erbB2 oncogene product to known prognostic indicators of colorectal cancer
1992
Collective cell migration in morphogenesis, regeneration and cancer
2009 Standout
neu oncogene protein and epidermal growth factor receptor are independently expressed in benign and malignant breast tissues
1990
Pulmonary involvement in lymphoma
1996
Squamous cell metaplasia in the human lung: molecular characteristics of epithelial stratification
1992
NEW EMBO MEMBERS' REVIEW: The ErbB signaling network: receptor heterodimerization in development and cancer
2000 Standout
Head and Neck Cancer
1993 Standout
Idiopathic Pulmonary Fibrosis
2001 Standout
Langerhans Cells and Epithelial Cell Modifications in Cervical Intraepithelial Neoplasia: Correlation with Human Papillomavirus Infection
1990
MicroRNA signatures in human cancers
2006 Standout
Protein tyrosine kinases and cancer
1997
Pulmonary carcinosarcoma: Immunohistochemical and ultrastructural studies
1999
Engineering of monosized lipid-coated mesoporous silica nanoparticles for CRISPR delivery
2020 StandoutNobel
Erlotinib in Lung Cancer — Molecular and Clinical Predictors of Outcome
2005 Standout
Epidermal growth factor receptor (EGFR) signaling in cancer
2005 Standout
Levels of TGF-α and EGFR Protein in Head and Neck Squamous Cell Carcinoma and Patient Survival
1998 Standout
Advances in Malignant Mesothelioma
2005 Standout
Inactivation of Merlin in malignant mesothelioma cells and the Hippo signaling cascade dysregulation
2011
Sequence and structure-based prediction of eukaryotic protein phosphorylation sites
1999 Standout
Thoracic Lymphangiomas, Lymphangiectasis, Lymphangiomatosis, and Lymphatic Dysplasia Syndrome
2000 Standout
Prognostic Significance of Histopathologic Subsets in Idiopathic Pulmonary Fibrosis
1998 Standout
Idiopathic Pulmonary Fibrosis
1998 Standout
Bcl-2 protein expression in lung cancer and close correlation with neuroendocrine differentiation.
1996
p53 Mutations in Human Cancers
1991 StandoutScience
Cyclooxygenase-2 overexpression is a marker of poor prognosis in stage I non-small cell lung cancer.
2001 Standout
Ligand-independent dimerization of oncogenic v-erbB products involves covalent interactions
1996
Expression of mutated epidermal growth factor receptor by non-small cell lung carcinomas.
1993
Epidermal Growth Factor Receptor in Non–Small-Cell Lung Carcinomas: Correlation Between Gene Copy Number and Protein Expression and Impact on Prognosis
2003
Germ Line p53 Mutations in a Familial Syndrome of Breast Cancer, Sarcomas, and Other Neoplasms
1990 StandoutScience
Serial computed tomographic evaluation in desquamative interstitial pneumonia
1997
Multifunctional Protocells for Enhanced Penetration in 3D Extracellular Tumoral Matrices
2017
Idiopathic Pulmonary Fibrosis: Prevailing and Evolving Hypotheses about Its Pathogenesis and Implications for Therapy
2001 Standout
Classification of human lung carcinomas by mRNA expression profiling reveals distinct adenocarcinoma subclasses
2001 Standout
Disturbance of Tumor Necrosis Factor Alpha-Mediated Beta Interferon Signaling in Cervical Carcinoma Cells
2002 StandoutNobel
Human tonsil intraepithelial B cells: a marginal zone-related subpopulation.
1992
Multicentric angiofollicular lymph node hyperplasia: A clinicopathologic study of 16 cases
1985
Epidermal Growth Factor Receptor Gene Expression in Normal Human Kidney and Renal Cell Carcinoma
1989
Immunogene Therapy of Tumors with Vaccine Based on Xenogeneic Epidermal Growth Factor Receptor
2003
Epithelial Tumor Markers: Cytokeratins and Tissue Polypeptide Antigen (TPA)
1987
Expression of epidermal growth factor receptor (EGF-R) in non-small cell lung cancer. Use of archival tissue and correlation of EGF-R with histology, tumour size, node status and survival
1989
Characterization of epidermal growth factor receptor in primary human non-small cell lung cancer
1989
Kaposi's sarcoma-associated herpesvirus-like DNA sequences in multicentric Castleman's disease [see comments]
1995 Standout
Cytokeratin 20 in human carcinomas. A new histodiagnostic marker detected by monoclonal antibodies.
1992 Standout
EGF receptor gene mutations are common in lung cancers from “never smokers” and are associated with sensitivity of tumors to gefitinib and erlotinib
2004 Standout
Suppression of Human Colorectal Carcinoma Cell Growth by Wild-Type p53
1990 StandoutScience

Works of Bruce Addis being referenced

Late Relapse of Desquamative Interstitial Pneumonia
1987
Problems in mesothelioma diagnosis
2008
Epidermal growth factor receptors in lung tumours
1987
Peripheral T-Cell Lymphoma Presenting with Angioedema and Diffuse Pulmonary Infiltrates
1988
Immunohistochemical markers of small cell carcinoma and related neuroendocrine tumours of the lung
1987
Low-Grade B-Cell Lymphoma of Mucosa-Associated Lymphoid Tissue Arising in the Thymus
1990
Pulmonary blastoma, carcinosarcoma and spindle‐cell carcinoma: An immunohistochemical study of keratin intermediate filaments
1985
Expression of epithelial and neural antigens in small cell and non small cell lung carcinoma
1986
Plasmacytoma of lymph nodes
1980
Thymoma: An integrated clinicopathological and immunohistochemical study
1986
Rankless by CCL
2026